- Category
- Micro (2024-25)
- Udyam number
- UDYAM-BR-06-0007783

Mildness Pharmaceuticals Private Limited
About Mildness Pharmaceuticals Private Limited
Data last updated:
Mildness Pharmaceuticals Private Limited is a private limited company based in Garhpura, Bihar, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 12 October 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U24230BR2020PTC048577. Its GSTIN is 10AANCM8975G1Z4 (Bihar).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ramanand Prasad Sah and Radha Kumari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Ramanand Prasad Sah Vill – Mauji Than Singh Mauji Hari Singh, Garhpura, Bihar, India – 848201.
As per the financials filed for FY 2025, the company reported a revenue of ₹30.09 Lakh, a growth of 13% compared to the previous year. For the same year it recorded a net profit of ₹58,958 (net margin 2%) and EBITDA of ₹59,607 (EBITDA margin 2%).
Mildness Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-BR-06-0007783).
Company details
Recognitions & Rankings of Mildness Pharmaceuticals
Contact details
Mildness Pharmaceuticals Private Limited's registered office is in Garhpura, Bihar. Its e-mail address is in the company report.
- Email
- Registered AddressC/O Ramanand Prasad Sah Vill – Mauji Than Singh Mauji Hari Singh, Garhpura, Bihar, India – 848201
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Mildness Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Mildness Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Mildness Pharmaceuticals Private Limited, buy the company report.
Financials of Mildness Pharmaceuticals Private Limited
FY 2025 filings availableMildness Pharmaceuticals Private Limited reported revenue of ₹30.09 Lakh (up 13% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 13% in the latest year. EBITDA rose 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹59,607 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹58,958 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2% | ||||
| Net Profit Margin | 2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mildness Pharmaceuticals Private Limited, buy the company report.
Board of directors of Mildness Pharmaceuticals Private Limited
Mildness Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ramanand Prasad Sah | Director | 12 Oct 2020 | 6 Years 0 Months | Current |
| Radha Kumari | Director | 12 Oct 2020 | 6 Years 0 Months | Current |
Peer comparison
Mildness Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Maxelon Pharmaceuticals Private Limited | ₹30.23 Lakh (FY 2025) | 5.0% | Naini, Uttar Pradesh, India | |||
| Thebes Pharmaceuticals Private Limited | ₹30.2 Lakh (FY 2025) | 58.0% | New Delhi, Delhi, India | |||
| Giniva Pharmaceuticals Private Limited | ₹30.19 Lakh (FY 2024) | -30.0% | Ellisbridge, Ahmedabad, Gujarat, India | |||
| Rubra Pharmaceuticals Limited | ₹30.15 Lakh (FY 2025) | -8.0% | Telangana, India | |||
| Mildness Pharmaceuticals Private Limitedthis company | ₹30.09 Lakh (FY 2025) | ₹58,958 | 2% | 13.0% | Garhpura, Bihar, India | |
| Sarosh Pharmaceuticals Private Limited | ₹30.04 Lakh (FY 2025) | 0.0% | Bahraich, Uttar Pradesh, India |
To see the full peer comparison of Mildness Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Mildness Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mildness Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Mildness Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 04, 2024.
GST
Mildness Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AANCM8975G1Z4 | Bihar | Active | 08 Mar 2022 |
To see the full GST registrations and return filing status of Mildness Pharmaceuticals Private Limited, buy the company report.
Recent activity
Mildness Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Radha Kumari was appointed as Director on 12 Oct 2020.
Frequently asked questions
Mildness Pharmaceuticals is an active private limited company based in Garhpura, Bihar, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 12 October 2020 (6+ years old) and is registered under CIN U24230BR2020PTC048577.
Mildness Pharmaceuticals has 2 current directors:
- Ramanand Prasad Sah - Director
- Radha Kumari - Director
The latest financial statements of Mildness Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Mildness Pharmaceuticals is 10AANCM8975G1Z4, registered in Bihar.
The CIN (Corporate Identification Number) of Mildness Pharmaceuticals is U24230BR2020PTC048577. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mildness Pharmaceuticals was incorporated on 12 October 2020, making it 6+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Mildness Pharmaceuticals by revenue are Maxelon Pharmaceuticals Private Limited, Thebes Pharmaceuticals Private Limited, Giniva Pharmaceuticals Private Limited, Rubra Pharmaceuticals Limited, Sarosh Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Radha Kumari was appointed as Director on 12 Oct 2020. Ramanand Prasad Sah was appointed as Director on 12 Oct 2020.
Yes, Mildness Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-BR-06-0007783).
The registered office of Mildness Pharmaceuticals is at CO Ramanand Prasad Sah Vill – Mauji Than Singh Mauji Hari Singh, Garhpura, Bihar, India – 848201.
Mildness Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.

